2016 - CCG Updates & Insights
- Diagnosed With Ovarian Cancer, a Researcher Mined TCGA Data to Study Her Own Disease
Faced the bleak prognosis associated with stage IIIC ovarian cancer, Shirley Pepke, Ph.D., used her computational biology background to study her own cancer in comparison to TCGA data. Pepke has now been in remission for a year.
- A Key Data Sharing Partnership: The Multiple Myeloma Research Foundation Donates Data to the GDC
The Multiple Myeloma Research Foundation (MMRF), an advocacy and research organization, has emerged as a leader in data sharing by donating robust datasets on multiple myeloma to the GDC. By sharing their data, they hope to energize research on multiple myeloma and facilitate advances in cancer care.
- Using Genomics to Better Treat Children with Cancer
Every year approximately 13,000 American children and their families receive a cancer diagnosis. By encouraging a collaborative model for pediatric cancer research and interrogating the genomic underpinnings of these diseases, NCI’s Center for Cancer Genomics aims to improve the effectiveness of childhood cancer treatments and preserve the quality of life of young cancer survivors.
- TCGA Data Leveraged for Developing FDA-Designated Breakthrough Therapy
Pharmaceutical company Loxo Oncology used TCGA data in research that led them to develop FDA-designated breakthrough therapy LOXO-101, a promising new targeted therapy for treating cancers with TRK fusions.
- Human Cancer Models Initiative Will Create Next Generation Cancer Models That Have Genomic and Clinical Data
The NCI announced a new international collaboration called the Human Cancer Models Initiative that will generate models of human cancers that more accurately represent tumor biology and the diversity of cancer.
- The Genomic Data Commons Expands with New Data Sharing Agreement
Foundation Medicine, Inc., a molecular profiling company, will contribute data from 18,000 patients in the FoundationOne database to the Genomic Data Commons (GDC).